Stay updated on Orally Administered AG-120 in Hematologic Malignancies Clinical Trial

Sign up to get notified when there's something new on the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new revision entry 'Revision: v3.5.4' was added to the record history and the previous 'Revision: v3.5.3' entry was removed, indicating an update to the site's version reflected in the history log.
    Difference
    0.1%
    Check dated 2026-05-16T09:27:02.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    This change updates the ClinicalTrials.gov page’s displayed revision/build label from v3.5.2 to v3.5.3, indicating a platform/version release rather than a study-record update.
    Difference
    0.1%
    Check dated 2026-04-25T05:33:19.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T00:20:46.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The record history shows a new revision v3.5.0 added and revision v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-20T03:43:27.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T21:34:05.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and Revision: v3.4.1 was removed, reflecting the latest site release.
    Difference
    0.1%
    Check dated 2026-02-12T02:20:46.000Z thumbnail image

Stay in the know with updates to Orally Administered AG-120 in Hematologic Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page.